Peter Kies

Insider Reports History

Entity
Individual
Signature
/s/ Peter Kies
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Kies:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INOVIO PHARMACEUTICALS, INC. CFO Common Stock 24.4K $318K $13.07 May 15, 2024 Direct
INOVIO PHARMACEUTICALS, INC. CFO Restricted Stock Unit 9.54K $125K $13.07 May 15, 2024 Direct
INOVIO PHARMACEUTICALS, INC. CFO Common Stock 375 $4.9K $13.07 May 15, 2024 By Spouse
INOVIO PHARMACEUTICALS, INC. CFO Common Stock Option 18.8K Feb 28, 2024 Direct

Insider Reports Filed by Peter Kies

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INO INOVIO PHARMACEUTICALS, INC. May 15, 2024 3 -$33.5K 4 May 16, 2024 CFO
INO INOVIO PHARMACEUTICALS, INC. Feb 26, 2024 8 -$28.3K 4 Feb 28, 2024 CFO
INO INOVIO PHARMACEUTICALS, INC. May 15, 2023 1 $0 4 May 17, 2023 CFO
INO INOVIO PHARMACEUTICALS, INC. Mar 11, 2023 3 -$35.5K 4 Mar 13, 2023 CFO
INO INOVIO PHARMACEUTICALS, INC. Feb 26, 2023 7 -$52.6K 4 Feb 28, 2023 CFO
INO INOVIO PHARMACEUTICALS, INC. Mar 11, 2022 3 -$101K 4 Mar 14, 2022 CFO
INO INOVIO PHARMACEUTICALS, INC. Mar 8, 2022 3 -$36.8K 4 Mar 9, 2022 CFO
INO INOVIO PHARMACEUTICALS, INC. Feb 26, 2022 5 -$40.4K 4 Mar 1, 2022 CFO
INO INOVIO PHARMACEUTICALS, INC. Jun 9, 2021 3 -$308K 4 Jun 11, 2021 CFO
INO INOVIO PHARMACEUTICALS, INC. Jun 3, 2021 1 -$80.3K 4 Jun 4, 2021 CFO